Clinical, Virologic, and Immunologic Correlates of HIV-1 Intraclade B Dual Infection Among Men Who Have Sex with Men

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2011 Nov 3

PMID 22045341

Citations 22

Authors

Mary E Pacold

Sergei L Kosakovsky Pond

Gabriel A Wagner

Wayne Delport

Daniel L Bourque

Douglas D Richman

Susan J Little

Davey M Smith

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the susceptibilities to and consequences of HIV-1 dual infection.

Design: We compared clinical, virologic, and immunologic factors between participants who were dually infected with HIV-1 subtype B and monoinfected controls who were matched by ongoing HIV risk factor.

Methods: The viral load and CD4 progressions of dually and singly infected participant groups were compared with linear mixed-effects models, and individual dynamics before and after superinfection were assessed with a structural change test (Chow test). Recombination breakpoint analysis (GARD), HLA frequency analysis, and cytotoxic T-lymphocyte (CTL) epitope mapping were also performed (HIV LANL Database).

Results: The viral loads of dually infected participants increased more over 3 years of follow-up than the viral loads of monoinfected controls, whereas CD4 progressions of the two groups did not differ. Viral escape from CTL responses following superinfection was observed in two participants whose superinfecting strain completely replaced the initial strain. This pattern was not seen among participants whose superinfecting virus persisted in a recombinant form with the initial virus or was only detected transiently. Several HLA types were over-represented in dually infected participants as compared to monoinfected controls.

Conclusions: These results identify potential factors for dual infection susceptibility and further define its clinical consequences.

Citing Articles

Nanopore Sequencing for Characterization of HIV-1 Recombinant Forms.

Mori M, Ode H, Kubota M, Nakata Y, Kasahara T, Shigemi U Microbiol Spectr. 2022; 10(4):e0150722.

PMID: 35894615 PMC: 9431566. DOI: 10.1128/spectrum.01507-22.

Full-Length Envelope Analyzer (FLEA): A tool for longitudinal analysis of viral amplicons.

Eren K, Weaver S, Ketteringham R, Valentyn M, Smith M, Kumar V PLoS Comput Biol. 2018; 14(12):e1006498.

PMID: 30543621 PMC: 6314628. DOI: 10.1371/journal.pcbi.1006498.

Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.

Song H, Giorgi E, Ganusov V, Cai F, Athreya G, Yoon H Nat Commun. 2018; 9(1):1928.

PMID: 29765018 PMC: 5954121. DOI: 10.1038/s41467-018-04217-5.

Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population.

Hebberecht L, Vancoillie L, Schauvliege M, Staelens D, Dauwe K, Mortier V PLoS One. 2018; 13(4):e0195679.

PMID: 29624605 PMC: 5889168. DOI: 10.1371/journal.pone.0195679.

Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Wagner G, Landais E, Caballero G, Phung P, Kosakovsky Pond S, Poignard P J Virol. 2017; 91(17).

PMID: 28615205 PMC: 5553187. DOI: 10.1128/JVI.00475-17.

References

Borrow P, Lewicki H, Hahn B, Shaw G, Oldstone M . Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994; 68(9):6103-10. PMC: 237022. DOI: 10.1128/JVI.68.9.6103-6110.1994. View

Xin K, Ma X, Crandall K, Bukawa H, Ishigatsubo Y, Kawamoto S . Dual infection with HIV-1 Thai subtype B and E. Lancet. 1995; 346(8986):1372-3. DOI: 10.1016/s0140-6736(95)92391-8. View

Zhu T, Wang N, Carr A, Wolinsky S, Ho D . Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J Virol. 1995; 69(2):1324-7. PMC: 188714. DOI: 10.1128/JVI.69.2.1324-1327.1995. View

Diaz R, Sabino E, Mayer A, Mosley J, Busch M . Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol. 1995; 69(6):3273-81. PMC: 189038. DOI: 10.1128/JVI.69.6.3273-3281.1995. View

Smith D, Richman D, Little S . HIV superinfection. J Infect Dis. 2005; 192(3):438-44. DOI: 10.1086/431682. View

Hoelscher M, Dowling W, Sanders-Buell E, Carr J, Harris M, Thomschke A . Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS. 2002; 16(15):2055-64. DOI: 10.1097/00002030-200210180-00011. View

Carrington M, Nelson G, Martin M, Kissner T, Vlahov D, Goedert J . HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999; 283(5408):1748-52. DOI: 10.1126/science.283.5408.1748. View

Streeck H, Jolin J, Qi Y, Yassine-Diab B, Johnson R, Kwon D . Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol. 2009; 83(15):7641-8. PMC: 2708622. DOI: 10.1128/JVI.00182-09. View

Gao X, Nelson G, Karacki P, Martin M, Phair J, Kaslow R . Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001; 344(22):1668-75. DOI: 10.1056/NEJM200105313442203. View

10.

Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W . Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994; 68(7):4650-5. PMC: 236393. DOI: 10.1128/JVI.68.7.4650-4655.1994. View

11.

Piantadosi A, Ngayo M, Chohan B, Overbaugh J . Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses. 2008; 24(9):1221. PMC: 2743231. DOI: 10.1089/aid.2008.0100. View

12.

Middleton D, Menchaca L, Rood H, Komerofsky R . New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 2003; 61(5):403-7. DOI: 10.1034/j.1399-0039.2003.00062.x. View

13.

Sala M, Zambruno G, Vartanian J, Marconi A, Bertazzoni U, Wain-Hobson S . Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol. 1994; 68(8):5280-3. PMC: 236474. DOI: 10.1128/JVI.68.8.5280-5283.1994. View

14.

Yerly S, Jost S, Monnat M, Telenti A, Cavassini M, Chave J . HIV-1 co/super-infection in intravenous drug users. AIDS. 2004; 18(10):1413-21. DOI: 10.1097/01.aids.0000131330.28762.0c. View

15.

Lichterfeld M, Yu X, Mui S, Williams K, Trocha A, Brockman M . Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007; 81(8):4199-214. PMC: 1866095. DOI: 10.1128/JVI.01388-06. View

16.

Jost S, Bernard M, Kaiser L, Yerly S, Hirschel B, Samri A . A patient with HIV-1 superinfection. N Engl J Med. 2002; 347(10):731-6. DOI: 10.1056/NEJMoa020263. View

17.

McCutchan F . Global epidemiology of HIV. J Med Virol. 2006; 78 Suppl 1:S7-S12. DOI: 10.1002/jmv.20599. View

18.

Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K . Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol. 2009; 84(5):2610-7. PMC: 2820922. DOI: 10.1128/JVI.01962-09. View

19.

Kishino H, Hasegawa M . Evaluation of the maximum likelihood estimate of the evolutionary tree topologies from DNA sequence data, and the branching order in hominoidea. J Mol Evol. 1989; 29(2):170-9. DOI: 10.1007/BF02100115. View

20.

Smith D, Strain M, Frost S, Pillai S, Wong J, Wrin T . Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006; 355(1):1-5. DOI: 10.1016/j.virol.2006.08.009. View